Non-Hodgkin Lymphoma | Tumor

CURE’s non-Hodgkin lymphoma (NHL) page is an extensive resource of cancer information featuring the latest NHL news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on non-Hodgkin lymphoma.

Patient Awarded $289 Million in Landmark Monsanto-Associated Cancer Case

August 13th 2018, 8:12pm

Article

Dewayne Johnson, a patient with cancer who claimed that Monsanto’s Roundup product was at the root of his non-Hodgkin lymphoma diagnosis in 2014, was awarded $289 million by a jury, as reported by the Associated Press.

FDA Approves Drug for Rare Non-Hodgkin Lymphoma Types

August 8th 2018, 8:28pm

Article

A new treatment has been approved to treat two rare forms of non-Hodgkin lymphoma.

Success in Cancer Care Doesn't Happen Overnight

August 7th 2018, 10:34pm

Article

With an incidence rate of about three cases per million people a year in the United States, Waldenstrom macroglobulinemia is a rare malignancy, and, therefore, has no widely used screening tools. Diagnosing the disease early and, most important, accurately is the art of medicine that remains to be perfected.

#Scananxiety

August 6th 2018, 10:18pm

Article

Sometimes, you're ill prepared for a scan that might change the course of your life.

Individuals Affected by Blood Cancer Feel Disease is 'Under Control'

July 11th 2018, 9:21pm

Article

A national survey demonstrated shared feelings across all blood cancer types about treatment options and their side effects, as well as other social, financial and emotional aspects.

CAR T-Cell Therapy Offers Hope in DLBCL

July 10th 2018, 7:58pm

Article

CAR-T cell therapy is generating excitement for the treatment of diffuse large B-cell lymphoma, according to an update from the JULIET trial.

Drug Duo Granted Priority Review to Treat Waldenstrom Macroglobulinemia

June 25th 2018, 6:50pm

Article

The FDA has granted a priority review to a supplemental new drug application (sNDA) Imbruvica (ibrutinib) for use in combination with Rituxan (rituximab) as a treatment option across all lines of therapy for patients with Waldenström macroglobulinemia.

Lymphoma Subgroup Experiences Durable Responses from Kymriah Treatment

June 20th 2018, 9:16pm

Article

Treatment with chimeric antigen receptor (CAR)-T cell therapy showed encouraging rates of durable responses among adult patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), according to updated data from the pivotal JULIET trial.

Great Expectations

June 19th 2018, 5:22pm

Article

Why the proverb, "you should never judge a man until you've walked a mile in his shoes" is true for both cancer patients and survivors.

First Roundup Case Goes to Court, But the Jury Is Still Out on Whether it Causes Cancer

June 19th 2018, 12:40am

Article

Dewayne Johnson is the first of hundreds of patients to take Monsanto to trial, claiming that Roundup caused them to get cancer. His case will be seen even sooner than others because in California dying plaintiffs can be given expedited trials.